alendronate and mycophenolic acid

alendronate has been researched along with mycophenolic acid in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jeffery, JR; Karpinski, ME; Leslie, WD; Nickerson, PW; Rush, DN	1
Panarelli, NC	1

Reviews

2 review(s) available for alendronate and mycophenolic acid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Drug-induced injury in the gastrointestinal tract. Seminars in diagnostic pathology, 2014, Volume: 31, Issue:2 Topics: Alendronate; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Bone Density Conservation Agents; Cation Exchange Resins; Colchicine; Ferrous Compounds; Gastrointestinal Diseases; Gastrointestinal Tract; Gout Suppressants; Humans; Imidazoles; Immunosuppressive Agents; Mycophenolic Acid; Paclitaxel; Polystyrenes; Tetracycline; Tetrazoles	2014

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Drug-induced injury in the gastrointestinal tract.

Seminars in diagnostic pathology, 2014, Volume: 31, Issue:2

Topics: Alendronate; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Bone Density Conservation Agents; Cation Exchange Resins; Colchicine; Ferrous Compounds; Gastrointestinal Diseases; Gastrointestinal Tract; Gout Suppressants; Humans; Imidazoles; Immunosuppressive Agents; Mycophenolic Acid; Paclitaxel; Polystyrenes; Tetracycline; Tetrazoles

2014

Trials

1 trial(s) available for alendronate and mycophenolic acid

Article	Year
Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation, 2003, Nov-27, Volume: 76, Issue:10 Topics: Adult; Alendronate; Azathioprine; Bone Density; Bone Resorption; Calcitriol; Calcium Channel Agonists; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone	2003

Article

Year

Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.

Transplantation, 2003, Nov-27, Volume: 76, Issue:10

Topics: Adult; Alendronate; Azathioprine; Bone Density; Bone Resorption; Calcitriol; Calcium Channel Agonists; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone

2003

Other Studies

1 other study(ies) available for alendronate and mycophenolic acid

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004